Popular Articles

Men Agree But Women Do Not When Rating Attractiveness
Hot or not? Men agree on the answer. Women don"t.
buy viagra
Study Finds Noninvasive Blood Test For Liver Fibrosis May Alleviate Need For Liver Biopsies For Some Patients With Chronic Hepatitis C
A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test panel is provided exclusively by Quest Diagnostics Incorporated (NYSE: DGX), the world"s leading provider of diagnostic testing, information and services.
plan for health
News of the day
Celera Presents Data Replicating Its Immunodiagnostic Assay To Detect Lung Cancer From Blood Serum
Celera Corporation (NASDAQ:CRA) announced yesterday the presentation of data replicating its novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer (NSCLC) in an independent cohort of individuals with lung cancer. This study was performed in collaboration with scientists at NYU Langone Medical Center, NY. A key outcome of the study was the validation of a 9 biomarker immunoassay on a cohort of samples that is enriched for stage I disease, important for screening of early stage disease. The assay detected lung cancer with 92% sensitivity at 93% specificity. The panel also accurately distinguished malignant cases from benign lung disease. The data is being presented at the 13th World Conference on Lung Cancer as part of the International Association for the Study of Lung Cancer (IASLC) in San Francisco, CA.
Health Insurance

Wanted - PCTs To Get Involved In Groundbreaking User Involvement Project, UK

Diabetes UK and NHS Diabetes have joined forces to deliver an innovative project that will support three primary care trusts (PCTs) in England to develop effective user involvement approaches in diabetes care. The charity is now seeking three organisations to become our local partners. About the project The "User involvement in local diabetes care" project will develop partnerships locally to create and support structured, systematic and sustainable user involvement in all aspects of diabetes care. User involvement allows people living with diabetes to influence the decisions taken about the services the NHS provides. These partnerships will provide support tailored to local need. In the later stages the project will share learning and good practice examples with services across the UK. Express your interest in taking part Initial expressions of interest to take part in the project must be submitted by 31 July 2009 - use our online form to express your interest. An innovative project "We want to make sure that the knowledge and experience of people with diabetes is respected, valued and drawn upon to influence and shape diabetes care," said Corinne McCrum, Project Manager for "User involvement in local diabetes care" at Diabetes UK. "This innovative project is extremely exciting and we would encourage as many organisations as possible to apply. We strongly believe that such partnerships will help them meet their obligations to involve and lead to better care for people with diabetes." Anna Morton, Director of NHS Diabetes, said: "Service user involvement in the design and delivery of diabetes services at a local level is a core principle that underpins the work of NHS Diabetes. This innovative project will help us to make that happen, not only in the three project areas but more broadly through the lessons we learn". Further information Are you interested in being part of this project? If so, please submit this online form by 31 July 2009. You will then receive further information on the selection process. Alternatively visit our User involvement section to find out more. Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):